浙江医药(600216.SH)拟参投合伙企业 投向银发经济/医药大健康领域
ZMCZMC(SH:600216) 智通财经网·2026-02-24 07:56

Core Viewpoint - Zhejiang Medicine (600216.SH) has signed a partnership agreement to invest in a fund focused on the silver economy and healthcare sector, committing 250 million yuan, which represents 31.25% of the total fund size of 800 million yuan [1] Group 1: Investment Details - The partnership agreement was signed on February 24, 2026, with CITIC Medical Health Equity Investment Private Fund Management (Beijing) Co., Ltd. as the general partner [1] - The total subscribed capital of the partnership enterprise is 800 million yuan, with Zhejiang Medicine contributing 250 million yuan [1] - The fund aims to invest in companies within the silver economy and healthcare sectors, enhancing the value of the invested enterprises [1] Group 2: Fund Management and Objectives - CITIC Medical Health Equity Investment Private Fund Management (Beijing) Co., Ltd. will act as the general partner, executive partner, and fund manager [1] - The fund's objective is to maximize returns for all partners through reasonable commercial efforts and to achieve a win-win outcome [1]

ZMC-浙江医药(600216.SH)拟参投合伙企业 投向银发经济/医药大健康领域 - Reportify